TY - JOUR T1 - Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6鈥�11鈥厃ears with severe atopic dermatitis JO - British Journal of Dermatology UR - http://dx.doi.org/10.1093/bjd/ljad124 PY - 2023/04/30 AU - Flohr C AU - Irvine AD AU - Cork MJ AU - Simpson EL AU - Wollenberg A AU - Deleuran M AU - Praestgaard A AU - Thomas RB AU - Rossi AB ED - DO - DOI: 10.1093/bjd/ljad124 PB - Oxford University Press (OUP) VL - 189 IS - 2 SP - 238 EP - 240 Y2 - 2025/09/10 ER -